Joe Almeida

Chairman,
President, CEO
Baxter

José (Joe) E. Almeida is chairman, president and chief executive officer of Baxter International Inc.

Every day, millions of patients and caregivers rely on Baxter’s broad portfolio of essential healthcare products, which can be found in dialysis centers, homes, clinics and innumerable hospitals worldwide.

Almeida assumed his current responsibilities at Baxter in January 2016. He is now leading the company through a period of dynamic transformation powered by accelerated innovation, operational excellence and strategic execution.

Prior to joining Baxter, Almeida was chairman, president and CEO of Covidien plc from 2012 through 2015. He previously served as president of Covidien's Medical Devices organization, and in several senior leadership roles at Covidien's predecessor, Tyco Healthcare. He has also held leadership positions at Wilson Greatbatch Technologies, American Home Products' Acufex Microsurgical division, and Johnson & Johnson's Professional Products division.

Almeida is a member of the board of directors of Walgreens Boots Alliance, Inc. He also serves on the board of trustees of Partners in Health.

A native of Brazil, Almeida received a Bachelor of Science degree in mechanical engineering from Instituto Mauá de Tecnologia.

Harjit Gill

Chief Executive Officer
APACMed

Harjit was appointed CEO of APACMed in February 2019. Founded in 2014, the Asia Pacific Medical Technology Association is the only regional association to provide a unified voice for the medical technology industry in Asia Pacific.

She was formerly EVP and CEO of Philips ASEAN & Pacific until October 2015. In this role, she managed a team of 10,000 people in 10 countries across its Healthcare, Lighting and Consumer Lifestyle sectors. Harjit spent over two decades with Philips holding a variety of international roles in General Management in England, Holland, Singapore, Dubai and Hong Kong.

Passionate about innovation and healthcare reform, she holds concurrent positions on several prestigious boards:

• Board Member, ResMed, a pioneer in cloud connected, innovative solutions, for people with sleep apnea, COPD, and other chronic respiratory diseases
• Board Member, MAS Holdings, South East Asia’s largest manufacturer of apparel and textiles
• Board Member, Apollo Education, a leading English Education provider in Vietnam
• Advisor, Delmedica, an innovative Singapore-based company that has developed the X-Halo, the world’s first breath thermometer for managing respiratory diseases.

She is a former Singapore Chapter Chair of the Young Presidents Organisation, the premier leadership organisation of Chief Executives in the world, and former Board member of the SICC, National University of Singapore Entrepreneurship Committee and World Economic Forum Global Agenda Council on South East Asia. Harjit has spoken at several global leadership platforms including the World Economic Forum, INSEAD and IMC on Innovation and Healthcare.

Andrew Frye

Senior Vice President & President, APAC
Baxter Healthcare
Chairman APACMed

Andrew Frye is senior vice president and president, APAC, for Baxter Healthcare and is the current Chairman of the Board of Directors for APACMed.

Andrew joined Baxter in 2017 from DKSH Holdings Ltd., where he served as Global Head of Healthcare from 2015 to 2017. In that role, he oversaw a portfolio of pharmaceuticals, over-the-counter and device products across 13 countries. Previously, he served as vice president of Business Development from 2011 to 2014 for DKSH Healthcare. Earlier in his career, he held a number of commercial roles with increasing responsibility at Abbott Laboratories’ Pharmaceutical and Nutrition divisions.

Andrew received a bachelor’s degree in psychobiology from the University of Southern California and master’s degree in marketing from the Anderson School of Management at the University of California. He resides with his family in Singapore.

Kevin Lobo

Chairman & CEO Stryker,
Chairman ADVAMED

Stryker appointed Kevin A. Lobo as Chairman of the Board on July 22, 2014, in addition to his responsibilities as Chief Executive Officer of Stryker, which he assumed on October 1, 2012. Mr. Lobo joined Stryker in 2011 and had previously been Group President of Orthopaedics.

Mr. Lobo is the chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors and serves on the Board of Directors for Parker Hannifin Corporation, the global leader in motion and control technologies. He is also a member of the Business Roundtable and Business Council.

Mr. Lobo has a broad business career that includes executive positions in general management and finance. After holding finance positions with KPMG, Unilever and Kraft Canada he spent eight years with Rhone-Poulenc, including roles based in Europe as Worldwide Corporate Controller of the chemical spin-out, Rhodia, and General Manager of Specialty Phosphates EMEA. He then spent eight years at Johnson & Johnson, including CFO of McNeil Consumer Healthcare and Ortho Women’s Health & Urology, President of J&J Medical Products Canada and President of Ethicon Endo Surgery.

Mr. Lobo's extensive global business and leadership experience across multiple industries, including healthcare, enables him to provide valuable insight to Stryker’s board regarding the company's operations and the strategic planning initiatives necessary to meet the demands of the changing environment. As the sole member of management on our board, he provides management's business perspectives and the necessary link to our day-to-day operations.

Ashley McEvoy

Executive Vice President,
Worldwide Chairman, Medical Devices
Johnson & Johnson

Ashley McEvoy is Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson and a member of the Executive Committee. In her role, Ashley leads the surgery, orthopaedics, interventional solutions and eye health businesses, which generate approximately $26B in revenue. Ashley oversees 70,000 employees across Ethicon, DePuy Synthes, Biosense Webster and Johnson & Johnson Vision.

Ashley inspires her teams to disrupt medical interventions to meet the needs of patients around the world. She spearheaded the acquisition of Auris Health in 2019 to accelerate the company’s entrance in robotics with a platform that is commercially available in the U.S. Under her leadership, there have been more than $6.5B in acquisitions and strategic collaborations in Medical Devices, representing 50 different deals to enable growth and address unmet patient needs.

She is a Credo-based leader who has delivered above-market performance for all four multi-billion-dollar, global companies she has led, and she is particularly adept at designing turnaround strategies for mission critical businesses. She advances diversity and inclusion to enable forward-thinking teams who can deliver results and drive industry change.

Her accomplishments have been recognized by numerous business and philanthropic organizations and she was named to Fortune magazine’s 2019 list of the “Most Powerful Women.”

Graham McLean

President, APAC
Stryker
Vice-Chairman, APACMed

Stryker has a long and proud record of leadership, commitment and support for the Medical Technology industry in Asia Pacific. Stryker operates in a very broad range of MedTech sectors including theatre and hospital equipment, beds, surgical consumables, neuro technology and orthopaedic implants (maxillio- facial, spine, joints and trauma).

Graham has worked for Stryker for 14 years with extensive experience across Asia Pacific. Graham’s current role is President Asia Pacific and he sits on the Stryker global Executive Leadership team.

Graham was formerly President of Stryker Australia/New Zealand and sat on the MTAA Board for 3 years, then President of Stryker Japan and sat on the AMDD Board for 2 years. He has front line experience of the challenges and issues in key markets in the region. Graham offers a unique set of skills and experience including 20 years of leadership in food and drinks businesses, consulting, as well as MedTech. He has governance experience, having worked closely with public listed company boards and voluntary organizations, is a member of the Institute of Company Directors and a qualified accountant.

James Lim

Executive Vice President & President,
Greater Asia
Becton Dickinson
Treasurer, APACMed

James Lim, Executive Vice President and President, Greater Asia for Becton Dickinson (BD), sits on BD’s Global Leadership Management Committee reporting to the CEO. Based in Singapore, BD’s regional headquarters, James leads the business operations in China, Japan, Taiwan, Hong Kong, Australia, and New Zealand, Korea, SEA, India and Pakistan.

James joined BD in 1994 from Seagate International. Starting as an Engineering and Facility Manager for BD Medical (Singapore), after a 3-year assignment in R&D, he became a Plant Manager in 2000. In 2003, he was promoted to the role of the Director of Operations for Asia Pacific, where he was responsible for the regional manufacturing and supply chain functions, overseeing plants operating in Singapore, Bawal, India, and Suzhou, China.

In April 2008, James was appointed as the Vice President for Central and Asia Pacific, holding responsibility for the Central Asia Business Management and support functions for the entire Asia Pacific region.

Four years later, James was appointed as President of Greater Asia and an Executive Member of the company, becoming the first Asian leader to take office in the region’s 30-year history.

A strong believer in developing and retaining the best of talents, James was conferred the Leading CEO award by the Singapore Human Resources Institute (SHRI) in 2014. The award was testimony to his championship of innovative and effective HR ideas and practices and demonstration of leadership commitment to talent development within the industry.

James received his early education in Malaysia and continued to study the National University of Singapore, where he graduated with a Mechanical Engineering degree.

Married and with two teenage sons, James tries to spend as much time as possible with them between his business travels. He is passionate about automotive and is an avid fitness enthusiast.

Ian Burgess

Chief Executive Officer
Medical Technology Association of Australia (MTAA)

Ian is CEO of the Medical Technology Association of Australia, the national association representing companies in the medical device industry.

Ian is a director of the Asia Pacific Medical Technology Association, which is headquartered in Singapore, and is also a director and Vice Chair of Red Nose, formerly known as SIDS & Kids, a well-respected not-for-profit organisation that is dedicated to saving the lives of babies and children.

Art Butcher

Executive Vice President & President,
Asia Pacific
Boston Scientific

Art Butcher is Executive Vice President and President for Boston Scientific in the Asia Pacific region, a role he has held since February 2020. Currently based in Singapore, Art is responsible for overseeing the continued growth of our business across Asia Pacific in line with our company values. He is a member of the Boston Scientific global executive committee.

Art has been with Boston Scientific for over 20 years. Prior to his current role, Art was President, Endoscopy with global responsibility for developing and bringing to market less invasive devices for treating gastrointestinal and pulmonary conditions. He was previously Vice President and General Manager, Endoscopy in Japan.

Art has held a variety of marketing and strategic planning management positions within the Endoscopy, Urology and Pelvic Health businesses, including Vice President of Global Marketing (Endoscopy) and Vice President of New Business Development and Strategic Planning (Urology and Women’s Health). He joined Boston Scientific in 1997 as a sales representative in the Urology business.

Art holds a BA in International Relations from the University of Pennsylvania and an MBA from Columbia University.

Probir Das

Chairman & Managing Director
Terumo Asia Holdings

Probir has three decades of medical technology industry experience and has extensively worked across medical-surgical, interventional, clinical diagnostics, infectious diseases, ophthalmology, and nutrition domains.

Probir has been with Terumo Corporation since 2012 and is currently responsible for overseeing its operations across Asia Pacific and India. As the Regional Leader of Asia Pacific & India, he spearheads Terumo’s investments into these emerging markets for purposeful talent and business strengthening, health system scaleup through various skill interventions, and driving the long-term strategy of Terumo in Asia Pacific.

Given his keen interest in policy shaping, Probir is actively engaged in advocacy and sits on the Board of Directors for the Asia Pacific Medical Technology Association (APACMed) and Medical Technology Association of India (MTaI). Probir also has over a decade’s teaching experience, specifically around strategy, leadership development, coaching and performance management. His passion towards MedTech sees him mentor start-ups and entrepreneurs.

Probir resides in Singapore and is a frequent visitor to all of the Asia Pacific markets and Japan.

Probir Das leads all of Terumo’s (leading global medtech corporation) business operations across Asia Pacific and India. He has 20 years of medtech leadership experience across Asia, along with 10 years of teaching experience with BD University and Terumo India Learning Council.

He is a board member of APACMed and a founding board member of MTaI. Probir previously held leadership positions at FICCI & NATHEALTH. His intense passion about healthcare ecosystem sees him support and mentor several entrepreneurs and start-ups.

Lam Chee Hong

President, Asia Pacific
B. Braun

Lam Chee Hong is the President and a Member of the Management Board of B. Braun Asia Pacific. As President, he is responsible for the Group’s pharmaceutical and medical technology business across the region.

Chee Hong begin his career with B. Braun in 1986 as a medical sales representative. In recognition of his leadership, versatility and business performance, he was continually entrusted with additional key responsibilities and ascended through the levels in the organisation to assume the most senior leadership role in B. Braun Asia Pacific.

Based in B. Braun’s regional headquarters in Penang, Malaysia, he also oversees B. Braun Group’s largest production sites in the world with over 7,700 employees.

Chee Hong graduated with a Bachelor of Economics from the University of Malaya. He is married and has two children.

Dr Bernd Montag

CEO
Siemens Healthineers

Bernd Montag, Ph.D., has been CEO of Siemens Healthineers since February 2015. As of March 2018, the company is listed on the Frankfurt Stock Exchange as Siemens Healthineers AG (SHL). Three months after its stock market debut, Siemens Healthineers entered the technology index TecDAX and in September that year Deutsche Börse also included the company in the mid-cap index MDAX.

Bernd Montag joined Siemens in 1995. He held positions in corporate quality management and sales in the hearing aid division before moving to imaging systems in 1999, where he served as a product manager for computed tomography and as the head of marketing for magnetic resonance business. In 2004, he assumed overall responsibility for computed tomography, and in 2008, he was named President of the Imaging & Therapy Division, which combined the overall business of diagnostic imaging and image-guided therapies.

Bernd Montag completed his studies in Physics at the Friedrich-Alexander-University, Erlangen-Nuremberg, and earned a Ph.D. in theoretical multi-particle physics. He was born in Munich, Germany, in 1969.

Chris Lee

Senior Vice President &
President, Asia Pacific
Medtronic

Chris Lee is Senior Vice President and President of Medtronic, Asia Pacific (APAC) and serves as a member of the Medtronic Executive Committee. He oversees the Medtronic APAC region where the company has presence in more than 20 countries with about 10,000 employees across the region. Chris joined Medtronic in 2012 as President of the Greater China region and was named as President of APAC in December of 2017. Under his leadership, the Greater China region achieved five consecutive years of double-digit growth by bringing meaningful innovation and expanding access to more patients locally.

Chris has a strong track record of global leadership in the healthcare industry — both in pharmaceutical and medical technology. He is known for his inclusive leadership style, commitment to meritocracy, and proven business success. During his time in China, Chris developed strategic partnerships with the Chinese government and was a strong supporter of corporate social responsibility — leading the company’s effective relief efforts to respond to the Lushan earthquake in Sichuan Province.

Prior to Medtronic, Chris was Regional Head and Senior Vice President, APAC at Bayer HealthCare where he was responsible for overall operations in the region, including pharmaceuticals, consumer over-the-counter, animal health, and medical devices. Chris has also held roles of increasing responsibility in several multinational companies, including Bristol Myers Squibb and Merck Sharpe and Dohme, while based in APAC and the U.S., respectively.

Chris is a pioneer in the management of workplace happiness and is the author of two bestselling books, one on emotional management and one on marketing. He was also formerly an executive director in the pharmaceutical industry associations of China (RDPAC), Australia (Medicines Australia), and Korea (Korea Pharma).
Chris serves on the board of the Asia Pacific Medical Technology Association (APACMed).

Chris holds a bachelor’s degree from the University of Arizona, Tucson and a master’s degree from the American Graduate School of International Management (Thunderbird). He is fluent in English and Korean, with a good understanding of Mandarin Chinese and Japanese.

Lance Little

Managing Director,
Region Asia Pacific
Roche Diagnostics Asia Pacific

Lance Little became the Managing Director, Region Asia Pacific for Roche Diagnostics in 2012. Prior to that, he was the Managing Director of Roche Diagnostics India (including the Indian sub-region). His experience as Managing Director extends to both Roche Diagnostics Thailand and Roche Diagnostics New Zealand.

Lance joined Roche in New Zealand in 1995 in the technical support and management division of Boehringer Mannheim’s Clinical Chemistry portfolio, before moving on to sales and marketing roles. He was appointed Managing Director of Roche Diagnostics Thailand in 2008 before returning to New Zealand to take up the role of Managing Director in 2009.

Lance started his career as a Medical Laboratory Scientist, specialising in Biochemistry at Auckland Hospital Laboratory in New Zealand. Following that, he spent some time managing the Automation Laboratory at Diagnostic Laboratories in Auckland.

Ashraf Hanna

COO
Verily

Ashraf Hanna is the Chief Operating Officer of Verily.

Previously he was the CEO of ORIC Pharmaceuticals, a company focused on the development of treatments for cancer resistance. Before that, Ashraf spent nearly 11 years as a Vice President at Genentech leading the Commercial and Medical Affairs Finance functions, as well as Alliance Management and Portfolio Planning group, which is responsible for developing metrics and guiding R&D investments.

Ashraf was also the CFO for the Genentech foundation, and previously at McKinsey and Company. He is a graduate of University of Chicago, has a Ph.D. in Physics from Harvard University and an M.D. from the University of Massachusetts.

John Groetelaars

President & CEO
Hillrom

John P. Groetelaars is President and Chief Executive Officer of Hillrom since May 2018.

Mr. Groetelaars most recently served as Executive Vice President and President of the Interventional Segment at Becton, Dickinson and Company, since December 2017 following its acquisition of C.R. Bard where his responsibilities included global strategic, financial, operational and innovation platforms.

He previously served in a variety of progressive roles at C.R. Bard during his 10-year career there, including as a Group President from 2015 to 2017. Mr. Groetelaars joined C.R. Bard in 2008 as Vice President and General Manager, Davol Inc., and was appointed President of Davol in 2009.

In 2013, Mr. Groetelaars was promoted to Group Vice President and in 2015 he was promoted to Group President, a position he held until C.R. Bard was acquired by Becton, Dickinson and Company in December 2017.

Prior to joining C.R. Bard, Mr. Groetelaars held various international leadership positions in Canada, Denmark and the UK at Boston Scientific Corporation from 2001 until 2008. Prior to joining Boston Scientific, Mr. Groetelaars held positions in general management, marketing, business development and sales with Guidant Corporation and with Eli Lilly.

Mr. Groetelaars serves as an Executive Director on Hillrom’s board, is Director of the ADVAMed board and is a member of The Economic Club of Chicago. Mr. Groetelaars earned his bachelor’s in Mechanical Engineering from Kettering University in Michigan, and an MBA from Columbia University in New York.

Sanjay Prabhakaran

Regional President,
Asia Pacific
Hologic

Sanjay Prabhakaran joined Hologic in July 2016 with more than 25 years of experience in medical devices, diagnostics and biotechnology across the Asia Pacific region.

Mr. Prabhakaran worked at Baxter International from 2007 to 2016, most recently as President, Asia Pacific, where he oversaw a commercial and manufacturing footprint exceeding $2 billion in sales with over 12,000 employees. From 1997 to 2006, Mr. Prabhakaran worked at Boston Scientific in senior leadership roles. He began his career at Boehringer Mannheim GmBH in India.

He is a member of the board of APACMed and has previously been a board member of AdvaMed in China, and has helped build government partnerships across the region.

He received a Bachelor of Technology degree in Electronics and Communication from Calicut University, and graduated from Harvard Business School’s Advanced Management Program.

Tim Schmid

Company Group Chairman, Medical Devices, Asia Pacific
Johnson & Johnson

Tim Schmid is the Company Group Chairman, Johnson & Johnson Medical Devices, Asia Pacific where he leads the company’s efforts to bring market leading surgical, orthopedic and interventional solutions to patients in need across Asia.

Tim has been with Johnson & Johnson for over 25 years and has held diverse leadership positions in sales, strategic marketing and general management across multiple businesses and geographies. Most recently, he served as Chief Strategic Customer Officer, where he led a transformation of Johnson & Johnson’s business-to-business relationships with hospital systems in the US. Prior to this he was President of Johnson & Johnson’s surgery business, Ethicon, where led a major turnaround in the US. This included the integration of five standalone businesses and the implementation of a new go-to-market model to address the rapidly changing needs of both clinicians and health care administrators.

Tim is a global executive who, in addition to leading business transformations across multiple continents, builds strong teams that have a track record of customer orientated solutions, growth and leadership across the medical technology industry. He is a champion for the value of diversity, currently leading the company’s diversity and inclusion efforts across Asia Pacific. He was also instrumental in establishing Johnson & Johnsons global partnership with Operation Smile, focused on bringing safe and effective surgical care to children suffering from cleft lip or cleft palate.

Educated in South Africa, Canada and the United Kingdom, Tim has lived and worked in six countries on four continents. He earned his undergraduate degree from the University of Western Ontario in Canada, and an MBA from Richmond University in the United Kingdom.

Elisabeth Staudinger

President, Asia Pacific
Siemens Healthineers

Elisabeth is President for Siemens Healthineers in the Asia Pacific region and is currently based in Shanghai, China.

Elisabeth joined Siemens in 1998 and held several roles with increasing responsibility spanning from procurement, strategy, manufacturing and R&D, and global CEO of the Refurbished Systems Business of Siemens Healthineers.

She moved to Asia in 2013 to lead the business of Siemens Healthineers across the entire portfolio spanning from Diagnostic Imaging, Laboratory Diagnostics, and Advanced Therapies in Asia Pacific. Her mission is to provide access to care and enable healthcare providers to increase value by making medicine more precise, changing the way care is delivered, improving the patient experience, and digitalizing healthcare.

Elisabeth studied in Vienna, Nanjing, and Beijing and holds a master’s degree in Economics from the Vienna University of Economics and Business as well as a master’s degree in Sinology from the University of Vienna. She is married and has one son.

Paul Tan Minjie

Divisional Vice President, APAC
Abbott

Julie Tay

Senior Vice President & Managing Director
Align Technology

Julie Tay is Senior Vice President and Managing Director, Asia Pacific, responsible for Align Technology’s market development and operational execution of all Align Technology products and services in the Asia Pacific region. She is also a member of the Executive Management Committee. She joined the company in March 2013 originally as Vice President and Managing Director, Asia Pacific.

Ms. Tay has more than 20 years’ experience in international management of various segments including consumer healthcare, medical devices and chemical businesses across Asia.

Prior to joining Align Technology, Ms. Tay was regional head of Bayer Healthcare (Diabetes Care) overseeing operations across Asia where she grew the business into a sustainable and profitable operation in three years. Prior to Bayer, Ms. Tay spent 15 years with Johnson & Johnson Medical where she was instrumental in establishing the LifeScan franchise within Asia.

Ms. Tay holds an M.B.A. from Curtin University of Technology (Australia) and a B.A. degree from the National University of Singapore.

Sunil Vasanth

Vice President, Surgical,
Asia Pacific
Alcon

Sunil Vasanth is currently Vice President, Surgical, Asia Pacific with Alcon. In his past four years with Alcon and Novartis, Sunil has held roles of increasing responsibility across the region. These have included country leadership (India), cluster leadership (India and South East Asia) and leading the Asia Pacific region with Alcon.

Alcon is the world’s leading eye care company, with excess of $7Bn in sales in its surgical and vision care business.

Sunil joined Alcon in March 2016 from Johnson & Johnson where he spent 21 successful years across a range of leadership roles in commercial and general management across India, Asia Pacific and the United States.

He was worldwide head of Global Strategic and International marketing for Johnson & Johnson’s Neuro business based in Boston, USA.

Sunil is passionate about improving standards of care globally and providing access to medical technologies especially in emerging countries.

Sunil has served on the board of Medical Technology Association of India (MTaI) as well as the executive committee of AdvaMed India.

Sunil holds both an electrical engineering degree and MBA from the University of Mumbai and has post-graduate certifications from IMD Business School and Harvard Business School.

Paul Grand

Chief Executive Officer
Medtech Innovator

Paul Grand is the founder and CEO of MedTech Innovator, the largest accelerator of medical devices in the world. The nonprofit accelerator seeks to improve the lives of patients by advancing companies poised to transform the healthcare system.

Prior to MedTech Innovator, Paul was a serial entrepreneur starting companies in the biopharma, medtech, and tech industries. He became a venture capitalist in 2005, when he joined RCT Ventures, an early-stage life science investor where he served as Managing Director. At RCT, Paul focused on medtech investments and sourcing innovation. He founded MedTech Innovator as a program within RCT Ventures in 2013 and left to run MedTech Innovator as a stand-alone company with RCT's support in 2016.
Paul has interacted with thousands of medical technology startups as part of MedTech Innovator’s rigorous review process to identify the most promising early-stage companies in the industry. Over 340 companies are now in MedTech Innovator’s portfolio, collectively bringing 54 products to market with a combined total of over $1.8B in follow-on funding.

Fredrik Nyberg

Managing Director,
Asia Pacific MedTech Innovator

Fredrik is the Managing Director Asia Pacific at MedTech Innovator, based in Singapore. He was most recently the Founding CEO of Asia Pacific Medical Technology Association (APACMed).
Fredrik brings over 30 years of healthcare industry experience, 25 of which were spent in Asia-Pacific. He has held senior sales/ marketing, general management and strategic consulting positions. Fredrik serves as Board Member and advisor to several healthcare startup ventures and is a frequent speaker on the healthcare industry in Asia-Pacific. He holds a BSc from Gothenburg University, Sweden, and an MBA from Henley Management College, UK.

Vibhav Garg

Director, Government Affairs Strategy,
India & ASEAN,
Boston Scientific

Mr. Vibhav Garg serves as the Director-Govt Affairs Strategy for India, India HUB & ASEAN and Head-Govt Business, India & India HUB for Boston Scientific. He has extensive global experience of over 19 years in the areas of Policy Advocacy, Brand Management, Regulatory & Compliance, Public Affairs, Corporate Communications, Crisis Management and has been engaging with state and federal government of India, South Asian, South East Asian and other developing countries for various strategic healthcare initiatives and policy discussions with concerned stakeholders.

Prior to rejoining Boston Scientific , Vibhav held various strategic positions with US & India headquartered organizations like GE Healthcare as Vice President-Health Policy & Govt Affairs, Boston Scientific India as Associate Director-Health Economics & Govt Affairs; Confederation of India Industry, the apex industry body in India, as Head of Life Sciences & Healthcare; Mascon Global Limited, a boutique management and IT consulting organization, spearheaded their healthcare and life sciences initiatives in India and US as well; and Brainwave Biosolutions Ltd where he lead the life sciences and healthcare practice of the organization. Most recently he was associated with Indian Pharmaceutical Alliance, the pharma trade association, as Associate Secretary General.

He is a pharmacy graduate from GJU, Hissar followed by Master of Engineering in Biotechnology from BITS, Pilani and Advanced Diploma in Business Administration from All India Management Association. He is currently pursuing Doctorate in Business Administration & General Management with specialization in Health Policy/Economics. His thoughts, views and research have been published in various peer reviewed journals and magazines and he has delivered many national and international invited lectures. Vibhav is currently Industry Co-Chair in Asian Harmonization Working party (AHWP) representing Indian Medical Device Industry and also chairing the Medical Equipment Subgroup of CII (Confederation of Indian Industry), in addition to being Co-Chair of FICCI Medical Device Policy Committee and Lead for UHC working group of APACMed India CoE. He was also the Vice Chair of AdvaMed (Advanced Medical Technology Association) in India and currently heads multiple other committees in trade associations like CII, FICCI, AmCham and other industry associations. He has also been advising various departments in different ministries of Government of India like Department of IT, Health, and Biotechnology in various capacities.

Niko Skievaski

President & Co-Founder
Redox

As President and Co-Founder of Redox, Niko Skievaski leads his team in helping healthcare organizations fulfill the promise of digital health – resulting in better patient outcomes and efficiencies for healthcare providers. In this role, he was named to Forbes 2017 30 Under 30 list of visionaries reinventing healthcare. He hosts The Redox Podcast and interviews leaders from across digital health.

Prior to founding Redox, Skievaski worked at Epic, one of the largest health tech companies in the world, and as an entrepreneur, economics lecturer, and advisor to startups. After Epic, he co-founded 100state (Wisconsin’s largest co-working community) and created ICD-10 Illustrated – a satirical book illustrating medical billing codes. Skievaski has an MA degree in economics from Boston University and a B.S. degree in economics and international business from the Arizona State University’s W.P. Carey School of Business. He lives in Boulder, Colorado, USA with his partner, toddler, and collection of mountain bikes.

Dr. K. Hari Prasad M.D

Group President – Hospitals
Apollo Hospitals Enterprise Limited

Stephanie Domas

Executive Vice President
MedSec

Stephanie Domas is the Executive Vice President of MedSec, a healthcare cybersecurity company exclusively focused on the unique challenges of protecting medical devices.
She leads the development of products and services to support medical device manufactures build more secure medical devices as well as healthcare delivery organizations and manage the risk of connected medical devices in healthcare environments.

Florian Then

Partner
McKinsey & Company

Torben Minko

Managing Director
B. Braun Vietnam Co., Ltd

Torben has been on assignments in Asia Pacific for over 10 years, since 2015 based in Vietnam. In his current position as Managing Director B.Braun Vietnam Co., Ltd. he is overseeing one of the largest German FDI with more than 1,400 skilled employees, two production facilities in Hanoi as well as sales and marketing office in HCMC. Over the last years, he has obtained a deep understanding about the business, political and bureaucratic environments in Vietnam where as his current position provides an exclusive insight about the healthcare system advantages and challenges.

Torben is active in the Vietnamese healthcare community and advocacy as Chairman of the Medical Device and Diagnostic Sector Committee (MDD) under EuroCham representing therewith 26 international member companies counting for more than 80% of the Vietnamese Medical Device market. Further to that, he is founding and board member of the International Quality Medicine Sector Committee (IQMed) under EuroCham representing viewpoints of European off-patent (generic) pharmaceutical companies.

Since 2019 Torben is Vice-Chairman of the German Business Association (GBA) actively representing German viewpoints and interests.

Since 2020 Torben is Board Member of the European Chamber of Commerce (EuroCham) promoting European sustainable investment and trade for more than 1,000 member companies.

Torben is based in Hanoi where he is living with his wife and two kids.

Sujay Mashru

Vice President &
Managing Director, Asia Pacific & Japan
Livanova

Sujay Mashru is Vice President & Managing Director, Asia Pacific & Japan for LivaNova. In 2018, he relocated to Singapore from London and is responsible for overseeing the rapid expansion of the business in more than 20 countries across the region.

He joined LivaNova (previously Sorin Group) in 2012 as Director, Corporate Strategy & Business Development based in both London, UK and Milan, Italy where he was focused on corporate strategic planning, mergers and acquisitions and driving other strategic initiatives focused on business model innovation.

In 2015, he was promoted to Vice President, Commercial Operations for Eastern Europe, Middle East, Africa, Latin America and Asia Pacific where he was responsible for overseeing business transformation projects, commercial strategy, channel partner management and commercial excellence for all business units.

Prior to joining LivaNova, he spent 8 years with Medtronic in its Cardiac Rhythm Disease Management division in various sales, marketing and field engineer roles across the US.

He holds a Bachelor of Science degree in Electrical Engineering from Purdue University and an MBA from INSEAD.

Sherina Ebrahim

Senior Partner
McKinsey & Company

Sherina Ebrahim is a Senior Partner at McKinsey & Company, Global Leader of McKinsey’s Enterprise Agility Tribe, and a leader in McKinsey’s Medical Products Practice. Over her 25 years with the Firm, Sherina has worked with medical products and consumer products companies across a range of topics including cross-cutting business transformation, strategy, growth, enterprise agility and commercial execution. Sherina holds a Masters in Business Administration with a concentration in Strategic Management from The Wharton School, University of Pennsylvania. She also holds a B.A. in Economics from Barnard College, Columbia University.

Danny Risberg

President,
Representative Director
Baxter Limited, Japan

Danny Risberg is General Manager of Baxter Limited. Danny joined Baxter in September 2018 after he served as the Chairman and CEO of Philips Japan for 10 years working across the Philips business sectors of HealthTech, Consumer and Lighting. He is well-experienced in medical device industry and has lead several industry groups in the medical and business sectors as former Chairman of the European Business Council Medical Equipment Committee and as the Chairman of the European Business Council (EBC) in Japan.

Prior to Philips Japan, Danny worked several years as a VP and CEO a for Fuji Respironics as the leader of their Asian operations. After a successful career helping its business gain a leading position in Japan and Asia Pacific, the Respironics group was acquired by Philips where Danny continued his efforts within the Philips Global organization. Danny is a Yale University Business Management (LEAP) program graduate. Born and raised in the US, he has 30 years of extended work and living experience in Japan, is fluent in Japanese. Danny enjoys fly fishing, cars and driving and enjoying time with his family in Tokyo.

Zhou Hui

Chairman
CCCMHPIE

Mr. Zhou Hui is the President of China Chamber of Commerce for Import & Export of Medicines & Health Products since November 2016. Before joining the Chamber, he used to be the Deputy Director General of the Department of Foreign Trade of Ministry of Commerce(MOFCOM).

From 2006 to 2015, he served consecutively as the Chinese Commercial Counsellor to Israel and Chinese Minister Counsellor to Indonesia. During the past 30 years, he has extensive experiences in bilateral and regional economic and trade cooperation. He graduated from the University of International Business and Economics and served as visiting scholars in Trade and Development Institute (Ireland), Manchester University (UK) and Boston University (USA) respectively in his early career.

Justin Leong

President
Asia & Latin America
ResMed

Justin Leong was appointed president of ResMed’s Asian and Latin American markets in June 2020, an extension of his role as president of ResMed’s Asia Growth Markets, held since September 2018, and the region’s senior vice president since May 2016. He joined ResMed in 2013 as vice president of Global Strategy, adding the role of General Manager of Greater China in 2015.

Before joining ResMed, Justin was a director at London-based investment firm HgCapital from 2006 to 2012, responsible for acquisitions and portfolio management, and serving on the board of directors of several European healthcare companies. From 1999 to 2004, he was a management consultant with Bain & Co. in Sydney, Boston and New York, where he advised clients on growth strategies, operational improvement projects, mergers and acquisitions.

Justin holds a Bachelor of Commerce and a Bachelor of Laws from the University of New South Wales, Sydney, and a Master of Business Administration from the Harvard Business School.

Rob Linden

Senior Partner
McKinsey & Company

Rob Linden is a Senior Partner at McKinsey & Company, Managing Partner of the Firm’s Silicon Valley Office and Global Leader of McKinsey’s Medical Products Practice. Over his 20 years with the Firm, Rob has served a wide range of medical products, diagnostics and biopharmaceutical companies on issues related to growth, globalization, commercial strategy, R&D productivity, operations and M&A / corporate finance. Prior to joining McKinsey, Rob was a corporate lawyer with Sidley & Austin in Chicago. He holds a J.D. from the University of Virginia and an A.B. from Stanford University.

Dr. Axel Baur

Senior Partner
McKinsey & Company

Axel is the leader of McKinsey’s overall Healthcare practice in Asia leading McKinsey’s work in Health Systems and Services as well as the Pharmaceuticals and Medical Products. Before moving to Asia, he co-led the healthcare practices in Germany, Europe, and the Middle East. He joined McKinsey’s German Office in 1996, and is highly experienced in the Healthcare practice as a whole, with expertise across many different topics, including large scale transformations in MedTech and pharma companies as well as in public and private health insurance systems. Since his arrival in Asia (initially Tokyo, now Hong Kong), Axel has been serving clients across Asia. MedTech and Pharma in Japan, local pharma unicorns in China, as well as Health Systems in South East Asia and private insurance organizations across Asia. Lastly, he has focused a lot on HealthTech and has served different players capturing the opportunity in the online-offline care continuum. Axel’s passion is to transform as well as to build together with his clients leading global institutions out of Asia. Axel also authored multiple publications, including “Building Excellence for Private Hospitals in Asia”, and “Prospect of German Healthcare Systems in 2040”.

Ken Cahill

CEO & Co-founder
SilverCloud Health

Ken Cahill is the CEO and co-founder of SilverCloud Health with offices in Boston, Dublin, and London. SilverCloud is the world’s leading digital mental health platform. It enables the delivery of clinically validated digital therapeutic care programs that are proven to significantly improve clinical outcomes, increase access & scale while reducing costs of care delivery.

SilverCloud’s multi-award winning platform has spun out from 16 years of clinical research with leading academic institutions, including MIT Media Lab. Today, SilverCloud provides customized solutions for over 290 organizations globally to meet the mental health & chronic care needs of their end users/patients. The platform has been profoundly validated through the use of full randomized control trials as well as real-world data from over 500,000 active SilverCloud end users. SilverCloud holds a CE Mark, ISO13485 Medical Device Designation as well as FDA roadmap.

Prior to founding SilverCloud Health, Ken held senior positions in several multinationals including, Dell, HP, and Gateway. Ken recently received the 2019 MedTech Boston 40 under 40 award.

He holds BSc. Degree in Computing, Diploma in new business and Diploma in company direction from the IOD

Corey McCann

President & CEO
Pear Therapeutics

Corey M. McCann, MD, PhD, is the President and CEO of Pear Therapeutics, a pioneer in prescription digital therapeutics, as the first company to receive market authorization for software to treat disease. Previously, Corey was an investor with MPM Capital, where he evaluated new healthcare investment opportunities, managed relationships with strategic partners, and oversaw strategy and execution at portfolio companies. Prior to MPM, he was an Engagement Manager with McKinsey & Company, where he advised pharmaceutical, medical device, and biotechnology companies on the acquisition, development, and commercialization of life science technologies. He led McKinsey’s central nervous system expertise group, advising clients across the healthcare value chain.

Corey has previous investment experience with RiverVest Venture Partners, where he performed diligence on early stage investments, and at NeuroInsights, where he evaluated brain-related technologies. Corey is also a co-founder, advisor, or Board Director at AgNovos Healthcare, Alcyone Lifesciences, Dragonfly Sciences, Edumedics, Resolute Bio, Selexys Pharmaceuticals, and Zillion Health.

Corey trained as a physician-scientist via the Medical Scientist Training Program. For his PhD, he studied the molecular biology of synapses at Harvard University and at Washington University in St Louis. He was also a post-doctoral researcher at the Massachusetts General Hospital where he developed imaging techniques for the visualization of the brain. He received his MD from Washington University in St. Louis. He graduated summa cum laude from The Pennsylvania State University where he was an Evan Pugh Scholar, receiving a BS in Biology with minors in neuroscience, biochemistry, and molecular biology.

Chang Liu

Regional Director for Singapore & Greater China
ACCESS Health International

Chang Liu, PhD, is responsible for the health and aging innovation platforms at ACCESS Health International and leads the research and consulting work for the region. Chang Liu has authored a number of publications, including the Singapore overview for the International Profiles of Health Care Systems from 2017, published by The Commonwealth Fund and London School of Economics, and the epilogue to Affordable Excellence, which documents progress toward sustainable high-quality healthcare in Singapore. He is currently working with Dr William Haseltine on another book about Singapore, A City for All Ages, on how the city-state is managing a rapidly aging population.

In addition to his work with ACCESS Health, Chang Liu is also an adjunct professor at the Chinese University of Hong Kong and Duke Kunshan University. Previously, he was an assistant professor in Health Services and Systems Research at Duke-NUS Graduate Medical School and the Center for Ageing and Education at Duke-NUS. He also worked at the Center for Gerontology and Healthcare Research at Brown University, where he studied long term care and elder care policies in both the United States and China. He earned his PhD in Health Services Research from Brown University with a specialization in health economics. He was awarded the eXebs Friedrich J.Schoening International Scholarship and was named an eXebs Fellow during his exchange study at the European Business School, Germany. He also received a Master's degree in Finance (2009) from the Guanghua School of Management of Peking University, China.

Dr. Rama Sethuraman

Director
Medical Devices Branch
Health Products Regulation Group, HSA

Dr. Rama is the Director, Medical Devices Branch, Health Sciences Authority (HSA). She oversees the pre-market registration and the post-market controls for medical devices in Singapore. She also oversees the device development consultation that aims to support safe innovation in medical technologies locally. She has been working in the area of Medical Device Regulations for over 10 years now.

Prior to joining the HSA, she was involved in Research on chronic pain and neuropathic pain at the National University of Singapore, identifying novel biomarkers related to pain and developing novel diagnostic methods using principles of chemistry in analysis of biological samples.

Dr Rama currently represents Singapore as a member of the Management Committee of the International Medical Device Regulators Forum (IMDRF).

Alan Goh (NDR)

CEO & Co-Founder
NDR Medical Technology

Alan Goh is the CEO and Co-Founder of NDR Medical Technology, Medtech start-up that develops surgical robotics, driven by Artificial Intelligence and Medical Image Processing to assist surgeons for minimally invasive surgery. He is also appointed as the Chairman for APACMed Start-up committee, guiding and building the medtech eco-system within Asia Pacific.

With a diverse background from Engineering Research, Medtech Manufacturing to Device Commercialisation, Alan was a winner in Slingshot 2018 and Medtech Innovator Asia-pacific 2019. He has successfully helped NDR raised Series A funding and inked partnership with Medical device Corporates across the region.

Lesley Maloney

International Regulatory Policy
Lead - Digital Health
Genentech

Lesley R. Maloney, Pharm.D., is Head, U.S. Regulatory Policy for Roche Diagnostics. In that role, she is responsible for guiding Roche Diagnostics’ regulatory policy efforts in the United States. In addition, she is also responsible for global regulatory policy efforts related to digital health.

Prior to joining Roche Diagnostics, she worked for the U.S. Food and Drug Administration in the Office of the Commissioner, where she served in various roles, including Deputy Chief of Staff, Senior Policy Advisor, and Deputy Associate Commissioner for External Affairs. Dr. Maloney holds a doctor of pharmacy degree from the University of Oklahoma and did an Executive Residency in Association Leadership and Management at the American Society of Health-Systems Pharmacists.

Christopher Kent

President & CEO
ODS Medical

Chris has served as the President and CEO of ODS Medical since its’ founding in 2015. Prior to ODS Medical, he worked with Dr. Kevin Petrecca, building a translational research program at the Montreal Neurological Institute focused on working with industry partners to accelerate the discovery and pre-clinical development of a wide variety of small molecules and biologics for treatment of brain cancers. He has published numerous peer-reviewed journal articles.

Prior to his work at the MNI, Chris was involved with a start-up that specialized in the application of stimuli-responsive polymer materials to a wide range of industries. As Director of Business Development and IP strategy, he developed the company’s business model, leveraging strategic industry collaborations in sectors such as packaging, textiles, energy and life sciences, into a growing patent portfolio which through subsequent development and out-licensing deals grew the company’s revenue ten-fold.

Jake Henry

Senior Partner
McKinsey & Company

Jake Henry is the co-convener of McKinsey’s global Pharmaceutical and Medical Products, and the leader of our Practice in North America.

Since joining the Firm in 2000, he has served numerous pharmaceutical and medical product companies, with a focus on corporate strategy, risk management, M&A, commercialization strategy and launch effectiveness, and geographic expansion. He previously led the Chicago location and the Medical Products Practice.

Jake has done extensive client work in the China and APAC markets across a range of sectors including pharmaceuticals, nutrition, and medical products. Jake is a frequent speaker at industry forums including APACMed and AdvaMed.

Prior to joining the Firm, Mr. Henry obtained a B.S.E. in mechanical and biomedical engineering from Duke University. He then completed his Ph.D. at Duke University in mechanical engineering, developing expertise in control systems, aerodynamics, acoustics, and vibrations. He currently serves on the Board of Visitors of the Pratt School of Engineering at Duke University.

Dr Raghav Murali-Ganesh

Co-Founder & CEO
Cancer Aid

Dr Raghav Murali-Ganesh completed his Medical Training at Nottingham University, UK. Following his move to Sydney, Australia, he undertook specialist training in radiation oncology at the Royal Prince Alfred Hospital, completing in 2016. Raghav has the ambition of improving healthcare outcomes with the use of digital tools.

Combining his oncology specialist knowledge, entrepreneurial skills and a vision for technology solutions, CancerAid has become the number 1 cancer app in Australia, the US and the UK. For building CancerAid into an innovative healthcare solution that can change cancer care on a global scale, Raghav has received prestigious honours including an appearance on Shark Tank 2017, Emerging Company of the Year 2017 (AusBiotech/Johnson & Johnson), Best Global Startup (Sir Richard Branson), Best Startup Creating Social Impact (Steve Wozniak) and the EY Accelerating Entrepreneur Award.

Dr. Pinaki Ghosh

Senior Manager,
Market Access & HEOR, APAC,
B Braun

Pinaki is a practicing Pharmacoeconomics/HEOR professional with 12 years experience in Health Technology Assessment. He holds a Ph. D. in Clinical Pharmacology & Pharmacoeconomics, and is an economist with advanced certifications in health economic modelling from University of Glasgow. He has worked with Invaluesys Research, Cardiff Research Consortium & Novartis in past. Currently he is Senior Manager, Health Economics, Asia Pacific, with B. Braun.

Dr. Shez Partovi

Worldwide Lead for Healthcare,
Life Sciences & Genomics
AWS

Dr. Shez Partovi obtained his medical degree from the prestigious McGill University, in Montreal, Canada and completed his neuroradiology subspecialty training at Barrow Neurological Institute in Phoenix, AZ. He is a serial entrepreneur and has launched a number of health IT companies, one of which was a telehealth company built on AWS.

After a decade of clinical practice, Dr. Partovi transitioned into executive roles at Dignity Health where he served as its Chief Health Information Officer and, subsequently, as Chief Digital Officer/SVP of Digital Transformation. As the CHIO, Dr. Partovi oversaw the deployment of Cerner across the enterprise in both inpatient, outpatient and oncology settings. As the CDO, Dr. Partovi was responsible for the digital experience of consumers, patients and providers across Dignity Health. Shez joined Amazon Web Services in 2018 as the Worldwide Lead for Healthcare, Life Sciences and Genomics. He is currently working on over a dozen large scale initiatives across the globe and has a unique perspective of the opportunities to transform healthcare worldwide. Dr. Partovi combines his clinical, entrepreneurial and AWS experience to help the audience Think Big and imagine the Art of the Possible.

Christophe Marque

Managing Director
Stereo Sdn Bhd
Chairman
Association of Malaysia Medical Industries

Christophe is a French citizen born in Paris.

He is the Managing Director of STEREO which specializes in Ethylene Oxide gas mixtures, developed for the industrial sterilisation of medical devices.

Stereo is now part of the Specialty Products division of Balchem (USA).

Christophe grew up in France and Africa; he has lived and worked in Asia since 1997, and relishes building and managing successful companies in Malaysia, Singapore, China, Philippines and Australia. Christophe is a sought after independent advisor on Strategy and Behavioral Economics.

Christophe is involved in various organizations, in the field of chemical industry, medical manufacturing, the United Nations and empowerment of underprivileged populations. He now lives on the island of Bali, with his wife and two children.

Christophe joined the AMMI Board as Director in 2013 and was Secretary General from 2015-2017.

He is now Chairman of the Board since 2018.

Martin Elling

Senior Partner
McKinsey & Company

Martin is a Senior Partner with McKinsey & Company. He has been with the Firm 27 years. While his practice has spanned many industries and geographies his main area of focus has been supporting Innovative medical products (devices, pharma) companies across NA, EMEA, APEC. A little over a year ago he was offered a chance to transfer to SEAsia to help anchor this fast growing region for the McKinsey. He is based in Bangkok where, in addition to supporting his global clients, he works across multiple industries and regions of Asia.

Dr. Jui Lim

CEO
SGInnovate

As CEO of SGInnovate, Dr Lim Jui has overall leadership of the organisation that is committed to helping entrepreneurial scientists build and scale Deep Tech startups. At SGInnovate, Jui and his team work closely with a wide range of partners and co-investors to back this unique group of founders, who are looking to solve global challenges with their research-based solutions. This is done through equity-based investments, access to the Deep Tech ecosystem and talent network, as well as by providing business-building support.

While he trained in medicine, Jui had spent most of his professional life in the business of science and innovation. He was Director of Investments, Bio*One Capital; CEO of Merlin MD, a medical device company; Executive Director of the Medical Engineering Research and Commercialisation Initiative (MERCI) at the National University of Singapore (NUS); and Programme Director of the Singapore-Stanford Biodesign Programme (SSB), a joint venture between the Agency for Science, Technology and Research (A*STAR), the Singapore Economic Development Board (EDB) and Stanford University. Before joining SGInnovate, Jui was CEO of NTUitive, the innovation and enterprise company of the Nanyang Technological University (NTU).

He currently serves on the advisory boards of IPOS International, the business arm of the Intellectual Property Office of Singapore (IPOS), and several start-up companies. He was previously a board member of the Building and Construction Authority (BCA) in Singapore.

Jui received his Bachelor of Arts (BA, Biological Sciences and East Asian Studies) and Doctor of Medicine (MD) at Columbia University. He then obtained his Master of Medicine (Anaesthesiology and Surgical Intensive Care) from NUS. He remains a registered medical practitioner today.

A firm believer in National Service (NS), Jui served 22 years as an operationally ready national serviceman (NSMan). In his final appointment as an NSMan, he was the Commanding Officer of an infantry battalion in the Singapore Army. Outside of work, he enjoys spending time with his family and friends over food, drinks and music. He then burns it off by running, most frequently in the trails around MacRitchie Reservoir.

Lih Chyun Yeong

Managing Director
B. Braun Medical Supplies Inc. President HTAP

LC Yeong is the President of Healthcare Technology Association of the Philippines & Managing Director of B. Braun Medical Supplies Inc. in the Philippines. Together with other 5 country leaders, he co-founded the first medical device industry association (HTAP) in the country in 2019. He has an extensive experience in the medtech industry spanning for over 20 years in Asia Pacific region owing to his various regional roles in B. Braun regional HQ prior coming to the Philippines in 2016. LC Yeong has a background on chemical engineering of McGill University and MBA graduate of University of Portsmouth.

Maryline Marquet

Vice President, Operations
APACMed

Maryline joined APACMed as its Vice President of Operations in February 2020. She manages the day-to-day operations of the APACMed Secretariat and is responsible for the scaling of the Association’s programme offerings to its members. She also advises both the Digital Health and Start-up and SMEs Functional Committees.

Prior to joining APACMed, Maryline led the commercial operations of several Singapore-based health tech start-ups, and previously held various sales and marketing management positions at Becton Dickinson, International SOS and Janssen.

Maryline designed healthcare solutions with customers in mind in Diabetes, Oncology, Neuroscience and Infectious Diseases to increase adherence and improve patients’ outcomes. She is a digital health leader with an in-depth knowledge of numerous conditions, and the commercialisation of digital services around them.

Passionate about healthtech, she speaks at many regional events and holds the following positions: • Board Advisor, Feeleat, a French start-up in food disorder. • Director, Avegen Health, an Indian start-up in maternal health and cardiac Rehabilitation. • President of INSEAD Alumni Healthcare Club of Singapore, organizing monthly events.

Maryline began her career in investment banking in US and consulting for both the Europe and Japan markets. She holds a Master of Science in Management from EDHEC Business School and a Master of Business Administration from INSEAD.

David Koh

Commissioner of Cybersecurity
Chief Executive, Cyber Security Agency of Singapore

Mr David Koh is the Commissioner of Cybersecurity and Chief Executive of the Cyber Security Agency (CSA) of Singapore.

As the Commissioner, he has the legal authority to investigate cyber threats and incidents to ensure that essential services are not disrupted in the event of a cyber-attack. Concurrently, as Chief Executive of CSA, he leads Singapore’s efforts to provide dedicated and centralised oversight of national cyber security functions. These include enforcing the cybersecurity legislation, strategy and policy development, cyber security operations, ecosystem development, public outreach and international engagement.

Mr Koh also sits on the Boards of the Government Technology Agency (GovTech), Defence Science and Technology Agency (DSTA), DSO National Laboratories (DSO), the Monetary Authority of Singapore (MAS) Cyber Security Advisory Panel and the Healthcare Cybersecurity Advisory Panel (HCAP).

Prior to his current appointments, Mr Koh served in the SAF and held various command and staff appointments in MINDEF and the SAF. He previously held the positions of Deputy Secretary (Special Projects) and Defence Cyber Chief of MINDEF, where he was responsible for leading and coordinating cyber defence policy, capability development, and operations for Singapore’s defence cluster.

Mr Koh is the recipient of the first Billington CyberSecurity International Leadership Award. He has also been awarded the Public Administration Medal – Gold, the Public Administration Medal – Silver (Military), the Public Administration Medal – Bronze (Military), and the Commendation Medal (Military).

Mr Koh has a Master’s degree in Public Administration from Harvard University, USA; and a Bachelor’s degree in Electrical and Electronics Engineering from King’s College, London, UK.

He and his wife, Marlene, have three children, Daniel, Rachel and Michael.

Abishek Shah

CEO
Wellthy Therapeutics

Abhishek Shah is the CEO of Wellthy Therapeutics, a digital therapeutics (DTx) company which inspires and enables people to prevent, manage and control their chronic health conditions. Prior to Wellthy Therapeutics, Abhishek co-led an early stage capital fund, where he invested, built and scaled healthcare ventures in Asia, prior to which he held leadership positions in a media conglomerate, a contract research and manufacturing pharmaceutical business, and a medical consumables business. Abhishek holds a B.S. in Chemical and Biomolecular Engineering from The Georgia Institute of Technology and an MBA from the Indian School of Business (ISB).

Adam Jarczyk

Head of Research
APAC
Ducker Frontier

Adam leads the Asia Pacific research team at DuckerFrontier. His work focuses primarily on supporting senior executives on key strategic initiatives such as resource allocation, go-to-market strategy, and risk management. Prior to joining DuckerFrontier, Adam was a Thomas J. Watson Fellow with a focus on Southeast Asia. He holds a bachelor’s degree in physics and East Asian languages and literatures from Washington and Lee University as well as a master’s degree in international economics and Asian studies from the Johns Hopkins University School of Advanced International Studies.

Bronwyn Le Grice

CEO, Managing Director, Founder
ANDHealth

Bronwyn has over 18 years executive experience in the health technology sector spanning venture capital, transaction management, capital raising, corporate development, investor relations and industry advocacy.

Formerly an Investment Director with leading healthcare VC, BioScience Managers, Bronwyn has managed over $65M of private and public equity capital raisings and been actively involved in over $30M of portfolio investments,

In 2017, Bronwyn founded ANDHealth, Australia’s only dedicated digital health accelerator & commercialisation support organisation. Now Australia’s leading health technology scale up accelerator, ANDHealth’s unique industry-led model has led to significant growth within Australia’s nascent digital health sector.

Bronwyn holds a number of health, technology and innovation advisory roles both in Australia and internationally. She has a Masters of Commercial Law from the University of Melbourne and a Bachelor of Commerce from the University of Western Australia.

Advisory roles: NSW Cyber Security Industry Standards Harmonisation Taskforce Data Governance Committee OUTBREAK RMIT University Health and BioMedical Sector Expert Research Advisory Group Swinburne University Innovation Precinct Advisory Board Australia New Zealand Leadership Forum Health Technologies Sector Group.

Dr Om Manchanda

Managing Director
Dr Lal PathLabs

Om Manchanda is the Managing Director of Dr. Lal PathLabs Ltd. In 1990, Om joined Unilever Group of Companies (now Hindustan Unilever) as management trainee. He worked for HUL for nearly 10 years in various positions.

In Nov’99, he moved on to Monsanto India Limited as their National Marketing Manager and thereafter as their National Sales Manager.

Early 2003, he joined Ranbaxy Laboratory Limited in their Global Consumer Healthcare Division before joining Dr. Lal PathLabs in October’2005.

He has successfully let the transformation of Dr. Lal PathLabs in nearly 15 years from a small business to a professionally run listed company.

He has done MBA from IIM Ahmedabad, and has around 30 years of work experience.

He has recently won prestigious “EY Entrepreneur of the Year” award for 2019 in the Healthcare and Life Sciences category.

Fabio La Mola

Partner, Global Healthcare Sector Co-Head, Executive Director L.E.K APAC Life Sciences Centre of Excellence, L.E.K Consulting

Fabio has over 20 years of experience working with clients to diagnose, design and implement strategies and organizations in Life Sciences in Asia Pacific, Europe and the Americas

He co-leads the Healthcare practice globally for L.E.K., and serves as Executive Director of the L.E.K. APAC Life Sciences Centre of Excellence

His experience in supporting clients spans from strategy to execution, organizational development and investment support: Business plan for new neurovascular clot retrieval device across APAC, from designing clinical development to commercialization and launch plan Review of major medtech multinational revenues opportunity across APAC, including vascular access devices and other capital and consumables Redesigned organization and go to market for major medtech multinational in North Asia

He earned his MBA at Kellogg School of Management, Northwestern University, and Business Administration Degree from Bocconi University in Milan

Gaobo Zhou

Healthcare Partner, Lead Pharmaceuticals & Medical Products
McKinsey & Company

Gaobo Zhou is a Partner of McKinsey & Company with 14 years of experience. He leads the Greater China Pharmaceutical and Medical Products practice and focuses on serving leading pharma and biotech companies on a broad range of topics, across business strategy, innovative commercial models, digital transformation, operation excellence, organization change, and capability building

Jim Sarka

Vice President & CIO – Business Technology - Asia Pacific
Johnson & Johnson
APACMed Digital Health Cybersecurity Working Group Chair

Jim Sarka is the Chief Information Officer and Vice President of Business Technology for Johnson & Johnson Medical Devices Asia Pacific. In this role, he serves as a technology navigator and strategist, leading the broader Medical Devices Technology Organization to identify, prioritize, and direct technology investments that best enables business growth.

Committed to serving as a technology business partner to executives across the region, Jim is a member of the Medical Devices Regional Business Leadership Team and Diversity & Inclusion Advisory Board. He chairs the Asia Pacific Johnson & Johnson CIO council and the APACMed Digital Health Cybersecurity workstream.

Prior to his current role, Jim led Johnson & Johnson’s Vision Business Technology Team for Asia Pacific, Japan, Latin America, Europe, Middle East & Africa Regions, as well as the Global Commercial Operations Product Line. During this time, he directed the global technology delivery of the MyACUVUE® mobile application and the ACUVUE Online Store enabling a Consumer Connected Commerce experience including Digital, Analytics and Sales Force Automation capabilities.

His Johnson & Johnson tenure has also allowed him to experience various technology roles spanning corporate functions, pharmaceutical, consumer, consumer medical devices and the hospital medical device segments in both supply chain and commercial spaces while living and working in three diverse geographies -- the United States, Latin America and Asia.

Jim is also incredibly passionate about nurturing, supporting and advocating for talent investment at Johnson & Johnson. He currently serves as the Asia Pacific Executive Sponsor for the Johnson & Johnson GenerationNOW Employee Resource Group, the Technology Leadership Development Program, and Operation Smile Community Impact.

Joe DeVivo

President
Hospitals & Health Systems
Teladoc Health

Joseph DeVivo leads the hospital and health systems business unit for Teladoc Health. Under his direction, the integrated platform and hardware business addresses the comprehensive needs of hospitals, health systems, retail clinics and physician groups globally.

Mr. DeVivo brings extensive leadership experience from across the medical device industry. Most recently, he was chief executive officer of InTouch Health, until its eventual acquisition by Teladoc Health in 2020. Prior to InTouch, he served as president, chief executive officer and director at AngioDynamics. Other leadership roles include global president of Smith & Nephew Orthopaedics, as well as vice president and general manager at U.S. Surgical/Davis, a division of Tyco International’s healthcare business.

Active in industry leadership as well as philanthropy, Mr. DeVivo is a member of the board of AdvaMed, American Telemedicine Association and St. Jude’s Children’s Research Hospital, raising over $1,000,000 for the benefit of the hospital. He holds a Bachelor of Arts in business administration from the E. Clairborne Robins School of Business at the University of Richmond.

Leanne Wells

CEO
Consumers Health Forum, Australia

Leanne has held executive positions in federal government and non-government organisations. Leanne is the Chief Executive Officer of the Consumers Health Forum of Australia and previously served as CEO of national peak and local service delivery organisations in the primary care sector. She is a health advocate and service executive with over thirty years’ experience in health and social policy, program and service development. Leanne has broad governance experience and is currently Board Director of Coordinare (South East New South Wales’ Primary Health Network), the Ozhelp Foundation, and the Australian Pharmacy Council, Independent Chair of Coordinare’s Community Advisory Committee and a member of the Healthdirect Clinical Governance Advisory Committee. She has several advisory appointments including the Commonwealth’s Primary Health Care Advisory Group, the National Preventative Strategy Advisory Committee and the OECD PaRIS Patient Advisory Panel. Leanne has tertiary qualifications in communications and business. She is a member of both the Australian Institute of Company Directors and the Australian Institute of Management.

Pablo Gonzalez

Head of Research
LATAM
Ducker Frontier

Pablo leads the Latin America research team at DuckerFrontier. His work focuses on helping executives stay abreast of key political, economic, and market developments affecting their business in Latin America. He also advises clients on strategic decisions, including market prioritization, go-to-market strategy, digital transformation, and organizational footprint in Latin America. Prior to joining DuckerFrontier, Pablo worked as a senior analyst for McKinsey Solutions and held various positions at JPMorgan, Banco Santander, and the Foreign Trade Office of Spain in São Paulo. Pablo holds a bachelor’s degree in business administration from Universidad Pontificia Comillas-ICADE and a master’s degree in international relations & economics, Latin American studies from Johns Hopkins University School of Advanced International Studies.

Pavan Choudary

Director General & Chairman, MTaI
CEO & MD
Vygon India

Mr. Pavan Choudary is the Managing Director of Vygon, a leading French Multinational in the field of Healthcare, He is the bestselling author of Healthcare and Management books like The Rx Factor and How a Good Person Can Really Win. He also has as his co-authors Dr. Kiran Bedi, the Lieutenant Governor of Pondicherry & Mr Anil Shastri, Ex Union Finance Minister. He has done a column with the Times of India, currently writes for Firstpost and is the TV Host of “Hum Aisey Kyun Hain” where he takes up several healthcare issues with leading doctors and policy makers of the country.

Two areas in medicine are especially close to his heart, Patient Safety & Quality in Healthcare and Safe Neonatal Vascular Access. He is the main person behind the Neonatal PICC movement in India. He is also one among the only two industry members, nominated by the GOI on the DTAB Sub Committee for provision of compensation for Medical Device Malfunction.

He is the recipient of several awards like the Intellectual Icon of the year award, Business Excellence Award, Eric Hoffer Award etc. He sits on some of the most prestigious advisory boards/boards of India in the commercial and socio-political space. Notable among these from the healthcare point of view are Medical Technology Association of India, Transasia Biomedicals, Lal Bahadur Shastri National Memorial Trust, Executive Access, Wisdom Smith PE Fund, Blue Circle (Unified Leadership Pvt. Ltd.) and Wisdom Village Publications.

He is consulted by leaders from different works of life on business & life. For more details, visit www.pavanchoudary.in.

Jeremy Lim

Co-Founder
AMiLi
(Asian Microbiome Library)

Jeremy is CEO of AMILI, the region’s first precision microbiome company. He volunteers with a number of charities including HealthServe where he serves as chair of the medical services committee.

Dr Sukyeong Kim

Senior Reserach Fellow
National Evidence-Based Healthcare Collaborating Agency (NECA)

Dr. Sukyeong Kim is Senior Research Fellow and International Cooperation Advisor of National Evidence-based Healthcare Collaborating Agency (NECA), Korean governmental agency for Health Technology Assessment. She plays the leading role in the field of health policy regarding local evidence generation and RWE, HTA system, R&D planning, optimal use of drugs, and patient safety. Recently, she also starts to participate in health industry policy researches regarding medical device industry, biopharmaceutical industry, and health care service industry in Korea Health Industry Development Institute (KHIDI).

Since 2013 she joined NECA, she undertook several research projects focusing on HTA system, patient safety & medical devices, and R&D for local evidence generation. For more than ten years before she Joined NECA, Dr. Kim played the leading role in the Korean pharmaceutical benefit policy making, drug utilization researches planning and new health technology assessment program development for medical procedures in Health Insurance Review and Assessment Service (HIRA) as the principle investigator and director of Pharmaceutical Benefit Division and Research Department.

As a representative of National HTA Agency of Korea, she has been the Chair of ISPOR HTA Roundtable Asia Pacific (2016~2019), one of the regional body composing ISPOR HTA Council. She has been participating regional and international meetings and workshops on HTA, medicine policy and UHC in Asia Pacific countries. Locally, she has been served as a committee member for Medical Devices Committee of Ministry of Food and Drug Safety and HTA & policy related societies.

Dr. Kim received her bachelor’s degree in Pharmacy from Seoul National University and Master and PhD degree in Health Policy from the Graduate School of Public Health in Seoul National University. She was a visiting scholar at the Graduate School of Health Studies in Simmons College, Boston, USA for Biotechnology and Pharmaceutical Industry study.

Dr. Arthur Brandwood

Director & Principal Consultant
BrandwoodCKC

As a founder and Principal Consultant of Brandwood CKC, Arthur has an international reputation for excellence. Arthur brings 35 years of experience in government, industry and academia, as well as a deep technical and regulatory knowledge, underpinned by a global network of relationships.

Arthur has held senior roles in the Australian Therapeutic Goods Administration (TGA) including as Director of Devices Assessment and Registration. He has provided support and training to multiple international regulatory agencies and served as adviser to the Asian Harmonization Working Party and to industry and professional bodies in Australia and internationally. Arthur’s consulting experience over two decades spans a wide range of technologies and geographies, and includes regulatory strategy, product development and testing, direct consultation with regulatory agencies, management of regulatory filings and resolution of complex and sensitive post market reviews.

Dr. Kelvin Loh

Managing Director & CEO
IHH Healthcare Berhad

Dr Kelvin Loh took the helm of IHH Healthcare as Chief Executive Officer (Designate) and Executive Director on 1 July 2019 before becoming Managing Director and Chief Executive Officer on 1 January 2020. With a clear focus on trust and transparency, he sets the strategic direction and leadership for IHH’s global healthcare services network, which comprises a strong stable of 76 hospitals and more than 15,000 licensed beds in 10 countries.

An experienced healthcare executive with strong track record of delivery, Dr Loh has extensive experience in leading large healthcare businesses, building relationships with stakeholders, managing hospital operations, financial management and developing people. He is also deeply familiar with the healthcare operating context in different countries across Asia.

Prior to joining IHH Healthcare, Dr Loh was with Columbia Asia Group where he oversaw its healthcare business comprising 28 hospitals across four countries in Asia as Chief Executive Officer since 2017.

Dr Loh spent the early years of his career as a practising general physician. Driven by a passion for healthcare systems improvement, he embarked on the management track in the public healthcare sector and widened his healthcare portfolios to include clinical services development, hospital planning and hospital management. In 2008, he joined IHH Healthcare where he served nine years in numerous senior management roles, including as Chief Executive Officer of Singapore Operations Division where he steered the group’s integrated healthcare businesses in Singapore.

Dr Loh holds a Bachelor of Medicine and Bachelor of Surgery and a Master of Business Administration from the National University of Singapore.

Dr. Chirag Adatia

Partner
McKinsey & Company

Hugh Terry

Founder
The Digital Insurer

Hugh Terry is the Founder of The Digital Insurer whose purpose is "working together to accelerate the digital transformation of insurance". Hugh has more than 30 years’ experience in the Insurance industry including operational, consulting and entrepreneurial roles. He is an actuary by profession and lives in Singapore. He is passionate about the application of technology to insurance business models and as well as writing articles he actively shares his experience via consulting assignments, speaking opportunities and participation in entrepreneurial initiatives in the field of digital insurance.

Kazuya Ogawa

Chairman & President, Zimmer Biomet G.K.
Chairperson
AMDD

Kenneth Daniel Tan

President
Asia Pacific & Japan
Varian Medical Systems

Kenneth Tan is the President for Asia Pacific and Japan at Varian Medical Systems. He joined Varian as the Senior Managing Director for Southeast Asia and Korea in January 2017. Varian is global leader in solutions for advancing cancer treatment; specializing in radiotherapy, radiosurgery, proton therapy, brachytherapy and oncology informatics software.

Varian is a pioneer in the development and commercialization of solutions that have successfully integrated remote diagnosis-planning, machine learning, artificial intelligence and cloud-based delivery.

Kenneth has 20 years of experience in healthcare; having held Commercial leadership roles in Varian, Medtronic, Covidien, Boston Scientific and Novartis. More than 14 years are in the implantable, disposable medical devices, capital equipment and managed services; covering various Global markets and regions in Asia Pacific. He has deep experience in the development and execution of strategic growth plans in China, Japan, India and South East Asia.

Kenneth has held various leadership roles in Sales, Marketing, Strategy and P&L Management. In recent years, he has built his success around driving difficult strategic shifts through organizations; in areas of business strategy and organizational transformation. The hallmarks of his tenure are growth acceleration, business-model innovation and a strong leadership team.

In the area of Organizational and Leadership development, Kenneth is passionate about “Fair-Process Leadership” and driving Diversity and Inclusion. He strongly believes that Purpose, Culture and Sustainability are key Strategy pillars for organizations to thrive in this new post-COVID19 world and attract a new generation of leaders.

Kenneth obtained his BBA from the University of South Australia and a diploma in Biotechnology (Medical Technology) from Singapore Polytechnic.

Caitlin Asjes

Senior Director
Government & Public Affairs
Greater Asia
Becton Dickinson

Julien Callard

Managing Director
Retail & Health,
AXA Singapore

Julien originally joined the AXA Group in 2000 and he has held senior positions across multiple countries spanning actuarial, risk, marketing and reinsurance. Prior to joining AXA Singapore, he was Head of Property and Casualty at AXA Mexico. He holds a doctoral degree in Finance and is a member of the French Institute of Actuaries.

Dan Vahdat

CEO & Founder
Huma

Alexander Vaagan

Chief Data Scientist
Crayon

Background

- Bachelor in Computer Science and Electronics

- 20 years experience as a software consultant

- 10 years experience with AI and ML

- Founder of Crayon’s AI initiative

Select project & leadership experience

- Early mover working more than 10 years hands on with AI for business improvement

- Lead SME on a large portion of Crayon’s ML projects covering a broad range of industries and ML domains

Marc Woods

Founding Partner
Equiida

A county standard swimmer as a teenager Marc had his left leg amputated because of cancer when he was 17.

Marc competed internationally as a swimmer for 17 years; winning 12 Paralympic medals from 5 Games and a further 21 from either World or European Championships. In the past he has held world records for 200m, 400m, 1500m Freestyle and as well as being part of the team that held the world record for 4 x 100m Freestyle. Since retiring from swimming in 2004 he has worked for both the BBC and CH4 at the Paralympic Games in Beijing, London and Rio.

Marc founded the Leadership Advisory business, Equiida, and now spends his time working with organisations around the world as an executive coach and speaker. He focusses this work around developing personal awareness, taking responsibility, leadership effectiveness, teamwork and inclusion.

Marc has written three books. Most notably Personal Best, a combination of his inspirational life story and personal development advice, and more recently Beyond the Call which, supported by research from New York University, looks at how to create conditions within an organisation that make discretionary effort more likely.

Sanjay Popat

Chief Executive Officer
Trabeya

Sanjay currently serves as the CEO at Trabeya. Mr. Popat has 22 years of experience in the field of Technology, Financial Services, Agriculture & Life Sciences. Prior to Trabeya, Sanjay Co-founded & was the CFO at Nucleus Biologics, a cell culture media company. Sanjay was the CFO at Tavistock Life Sciences, a Tavistock Group company focusing on investing in Life Science companies. As part of Tavistock Group, Sanjay has led executive management roles for various portfolio companies, including the Head of Finance and Operations of CovX (sold to Pfizer for $640M). Prior to joining the Tavistock Group, Sanjay worked at Insight Management and UBS Global Asset Management in earlier part of this career. Sanjay holds a graduate degree in Finance and Information Management from Stuart School of Business, IIT and undergraduate degree in accounting from Gujarat University in India.

Sadiqa Mahmood

General Manager & Senior Vice President Life Sciences Business
Health Catalyst

Sadiqa Mahmood, BDS, MPH is the Senior Vice President and General Manager of the Life Sciences business at Health Catalyst and contributes to the overall vision and growth for the company. Sadiqa’s work focuses on identifying and addressing areas of high unmet need for therapeutic development through application of real-world data. She is an advisor to several healthcare organizations and global policy makers. Sadiqa is a dental surgeon and holds a master’s degree in public health from the Harvard School of Public Health.

Passionate about improving access to care and patient outcomes by leveraging data and healthcare ecosystem, Sadiqa has spent her career at the intersection of medicine, policy, technology, and analytics. Previously she led clinical analytics, quality and safety, value-based contracting, and population health across healthcare organizations, including the Dana-Farber Cancer Institute, Partners HealthCare System, and Boston Medical Center. Sadiqa has been an advocate of collaborative learning system in healthcare and has steered cross-industry multi-stakeholder national and global collaborations to drive healthcare innovation.

She joined Health Catalyst in 2019 as SVP of Medical Affairs. Sadiqa has lived and worked in Asia and UK in addition to the US. She is based in Boston, Massachusetts. Outside of work, she is a Formula 1 fan and race as a member of a local team.

Ankur Pandey

Vice President
Healthcare
DKSH Myanmar Ltd.

July 2019 till Current – Heading the Healthcare business for DKSH Myanmar through passionate & committed team of 1000+ Employees. Responsible for all healthcare segments Rx, Consumer health & Medical devices for all business models.

March 2018 till June 2019 – Heading Healthcare business for DKSH Singapore & instrumental in expanding the commercial outsourcing business for the company.

August 2013 till Feb.2018 – Heading DKSH Myanmar Healthcare’s Alliance Business unit & responsible for total sales & marketing operations for the company through a team of 300+ sales & marketing specialists.

March 2011 till July 2013 – As Country Head, Myanmar for Torrent Pharmaceuticals responsible for growing the business to double the revenues in 2 years.

Anupam Sahay

Managing Director &
Senior Partner
BCG

Anupam is a Managing Director & Senior Partner at BCG, based out of the Singapore office. He advises leading Asian and global insurers across a full spectrum of industry topics. He has extensive international experience in health insurance, as well as life and general (P&C) Insurance. He has worked with clients on strategy, distribution, digital, new businesses, operations, and governance.

Anupam was a member of the Group Executive Committee at a multinational Insurer, and served as Group Strategy & Development Director and Managing Director Asia-Pacific

He was formerly a Partner at McKinsey, working in international Financial Services, based out of London.

Anupam studied management at IIM Calcutta and engineering at BITS Pilani.

Eugene Chow

Senior Consultant
Ernst & Young

Eugene was studying physical theater at Lecoq when covid hit him. After a week of dizziness and nightmares, he was diagnosed and warded, and soon after blacked out multiple times. He recovered from covid with the help of HCQ, and lots of yoga.

Ashley Yeo

Medtech Insight
Healthcare Editor
Informa Intelligence

Ashley Yeo is a healthcare and executive editor within Informa Intelligence’s pharma division, focusing on medtech, healthtech and diagnostics news and trends. His current titles are Medtech Insight and In Vivo, which provide global regulatory and commercial updates, and innovation thought leadership themes for the changing world of healthcare delivery. He has edited several industry titles in over three decades at the group.

Himanshu Baid

Chairman
CII Medical Technology Division
Managing Director
Poly Medicure

Himanshu Baid, aged 52 years is the Managing Director of Poly Medicure Limited (POLYMED). He holds a bachelor’s degree in Engineering (Electronics and communication). Himanshu worked with Philips Communication Industries as a trainee Engineer for 6 months in Nurenberg, Germany.

He is very passionate about doing business development inside and outside the country and his moto is to provide Medical Devices at an affordable cost to the society.

He started POLYMED in 1995 with his brothers and has over 23 years of experience in manufacturing of disposable medical devices. Himanshu is involved in Corporate strategy, Finance and Sales & Marketing Initiatives at POLYMED.

Under leadership of Himanshu, POLYMED today is:

• Largest exporter of consumable Medical Devices for last 8 years from India (Over Rs. 400 crores exports per year to 110+ countries).

• 9 manufacturing plants. Over 3 Million Devices manufacturing capacity per day. More than 130+ products.

• Highest number of Medical Devices patents granted – 215+ patents.

• Over 5000 employees. 50+ people working in R&D Team.

• Revenue of over Rs. 700 Crores.



Himanshu is also the Chairman of CII Medical Technology Division and NATHEALTH’s Governing Council Member.

Himanshu has keen interest in Sports (Cricket & Tennis) and devotes his free time for CSR activities.

Bruno Occhipinti

Founder & Lead Consultant
CrestaLab

Bruno Occhipinti is a tech sector exponent of innovation and long-term global strategy in the fields of Healthcare and Tech, across Asia and Europe, currently as an independent consultant for CrestaLab, and previously for multinationals, such as Philips, Samsung, and Hyperion (Oracle).

Since April 2019, he has been running the boutique consulting firm CrestaLab to coach consult & advise corporations that enable equitable access to quality care via novel health solutions. CrestaLab builds health & wellness ecosystems and innovative business models leveraging digital health within Asia Pacific.

In his former role in Philips APAC, Bruno designed and executed strategies for affordable care in emerging markets, chronic-care management, and telehealth. He championed innovation as part of the Country Management Team, fostering engagement with start-ups, and building thought-leadership through major conferences: Innov8rs, APAC MedTech, SMU Tri-Sector Forum: Partnership-driven Innovation,… He also led the new business of Affordable Care in APAC, developing synergies across the organization, and activating international cross-sector alliances.

Previously based in Philips headquarters in Amsterdam, Bruno led management consulting projects across all businesses for the Executive Committee. Beforehand, he handled corporate development in the solar energy venture of Samsung, after two years as a Global Strategist at the group’s headquarters in Seoul. Prior to that, he led several roles in pre-sales, product management, and consulting in data analytics for Hyperion (Oracle Group) in APAC and Europe.

Bruno holds an MBA from the Wharton School and graduate degrees in International Studies, International Finance, and Entrepreneurship. He is also a Certified Integral Life Coach.

Sylvain Goblet

Chief Digital Officer
Fibronostics & SPRIM Ventures

Sylvain has over 20 years’ experience in driving digital innovation in Telecoms, healthcare and consumer health. The first major digitally disruptive service in launched was the first mobile macro payment service in Europe in the early 2000, which generated over 200M Euros in its second year of Service. At J&J, Sylvain developed the digital health strategy, and incubated a line of patient management solutions for the Pharma and Med Devices businesses. He also headed the design to value for J&J’s $4 Billion+ APAC Consumer Health portfolio. While Chief Product Officer for Biofourmis, a rising digital therapeutics start-up, Sylvain built the product strategy, team, and platform, leading to $35Million in funds raised. As head of digital operations for SPRIM Ventures, Sylvain’s role is to accelerate the growth of their digital assets. He is building the digital strategy and platform play, as well as accelerating commercial results in APAC. Sylvain is an ex McKinsey consultant and Columbia business school graduate with a passion for developing disruptive value-based businesses, using diversity as a driver of team performance.

Dr. Ravinder Singh Sachdev

Deputy Chief Medical Informatics Officer
Tan Tock Seng Hospital

Anish Bafna

Chief Executive Officer
Managing Director
Healthium MedTech Pvt. Ltd.

Kavita Rekhraj

Partner
Life Sciences and Healthcare Industry Leader
Deloitte Southeast Asia

Farhana Nakhooda

Senior Vice President - Healthcare and Life Sciences
Health Catalyst

Farhana Nakhooda is the SVP of Healthcare & Life Sciences, Asia Pacific at Health Catalyst. She contributes to the overall vision and growth strategy of their Healthcare and Life Sciences business across Asia Pacific. Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, committed to being the catalyst for massive, measurable, data-informed healthcare improvement.

She has more than 20 years of international experience in the healthcare and life sciences industry as medical researcher and as a subject matter expert. She has played a key role in healthcare transformation projects in Singapore, Australia, India, Malaysia, South Korea, Japan, China, New Zealand, Vietnam, Thailand as well as Europe and Middle East/Africa. She has a long-standing reputation of patient advocacy and approaches her work with as passion and commitment the transformation enabled by technology. She has been invited to speak as an industry expert at events, press interviews and other healthcare/life sciences forums in multiple countries globally.

Farhana has a degree in Bachelor of Science (with Honors), in which she majored in Biology and Biochemistry, at the University of British Columbia. She completed her MBA at Monash Mt Eliza Business School in Melbourne, Australia, in December 2000.

Virginie Barbot

Head of SEA, Technology
Nasdaq

As Head of Singapore and South Asia at Nasdaq Market Technology, Virginie Barbot is responsible for Nasdaq Market Technology’s business in the region, supporting both market infrastructure operators and clients in other industries beyond the capital markets in their technology journeys. Prior to joining Nasdaq, she spent 8 years at Deutsche Boerse Group leading the Market Data and Analytics Services business for the German exchange operator. With her extensive experience in financial technology combined with market data and analytics, she is currently focused on developing Nasdaq’s technology offering for new markets segments in Singapore such as healthcare and shipping & logistics. Virginie has been a resident of Singapore for the past 13 years, since relocating from London.

Melissa Teoh

Chief Marketing Officer & General Manager
MyDoc

Melisa has lived and worked in 10 cities in Asia where she was responsible for building brand equity and value propositions, and has won industry awards for Aviva, Great Eastern, Nestle, Unilever to name a few. Prior to MyDoc, Melisa was Marketing Director for Singapore Life where her work helped to secure $50M in Series A, and was Chief Marketing Officer at CXA Group where her work helped secure a funding of $25M in Series B at a valuation of $100M.

Manoj Madhavan

Managing Director
Boston Scientific India

Preetha Reddy

Vice Chairperson
Apollo Hospitals

Preetha Reddy is the Vice Chairperson of Apollo Hospitals, Asia’s foremost integrated healthcare provider. She is widely recognized for her contributions in making high quality healthcare accessible to millions across India. She is the Managing Trustee of Apollo Hospitals Education Trust; a principal body steering the educational endeavours of the group.

She works closely with the organization’s 9000 clinicians in introducing contemporary protocols to continuously enhance clinical outcomes. She leads the thrust on quality improvement processes to achieve the highest standards of patient satisfaction. Apollo Hospitals has touched the lives of over 150 million individuals.

Preetha Reddy is the President of NATHEALTH – Healthcare Federation of India and she works closely with the Government of India to advance progressive policy decisions in healthcare.

Stephen Sunderland

Partner
L.E.K. Consulting

Stephen has two decades of experience as a strategic advisor and leads L.E.K.’s medtech practice in China and L.E.K.’s Digital Health practice in Asia. He also works across the biopharmaceutical and healthcare services sectors.

He has advised on organic and digital growth investments as well as partnering and M&A situations, working with some of the largest investors and most complex multinational healthcare enterprises in the world, as well as smaller innovative startups. He also works with governments and industry associations.

Stephen has been invited to share his perspectives on China’s healthcare industry development at various industry gatherings including Healthcare Business International and Healthcare Capital and Connections Summit, as well as published in various journals including In Vivo, Bioworld, Orthoknow, Medtech Dive and MedTech Strategist.

Stephen joined L.E.K. in London, and has supported L.E.K.’s growth in China since 2005. He holds a Masters in Manufacturing Engineering from the University of Cambridge.